CN104606338A - 一种安神养心冲剂及其制备方法 - Google Patents
一种安神养心冲剂及其制备方法 Download PDFInfo
- Publication number
- CN104606338A CN104606338A CN201410815503.4A CN201410815503A CN104606338A CN 104606338 A CN104606338 A CN 104606338A CN 201410815503 A CN201410815503 A CN 201410815503A CN 104606338 A CN104606338 A CN 104606338A
- Authority
- CN
- China
- Prior art keywords
- parts
- electuary
- nerves
- calming
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002216 heart Anatomy 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 239000008187 granular material Substances 0.000 claims abstract description 20
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 12
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 12
- 229920002472 Starch Polymers 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 235000019698 starch Nutrition 0.000 claims abstract description 9
- 239000008107 starch Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract 2
- 238000004806 packaging method and process Methods 0.000 claims abstract 2
- 210000005036 nerve Anatomy 0.000 claims description 36
- 230000001914 calming effect Effects 0.000 claims description 31
- 239000004615 ingredient Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 239000002671 adjuvant Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 239000004411 aluminium Substances 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 239000010419 fine particle Substances 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 238000012858 packaging process Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 240000000249 Morus alba Species 0.000 abstract description 5
- 235000008708 Morus alba Nutrition 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 3
- 229920001353 Dextrin Polymers 0.000 abstract 1
- 239000004375 Dextrin Substances 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000019425 dextrin Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 244000126002 Ziziphus vulgaris Species 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 240000008397 Ganoderma lucidum Species 0.000 description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- -1 neoliquriitin Chemical compound 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- RIXNFYQZWDGQAE-DFHVBEEKSA-N (4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-acetyloxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C([C@H]1C2=CC[C@H]34)C(C)(C)CC[C@]1(C(O)=O)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C RIXNFYQZWDGQAE-DFHVBEEKSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 240000007185 Albizia julibrissin Species 0.000 description 2
- 235000011468 Albizia julibrissin Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical compound C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000722818 Aralia Species 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001279228 Campylotropis hirtella Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000612122 Myrsine Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种安神养心冲剂,其由以下重量份数比的原料制备而成,其中,主料:灵芝3-6份、女贞子1-3份、龙眼干2-5份、甘草1-2份、酸枣仁2-6份、绞股蓝2-4份、合欢皮1-3份、丹参2-3份、柏子仁1-3份、桑葚子1-4份,辅料:淀粉35-80份、精糊15-55份。其制备方法包括:粉碎、提取、浓缩干燥、制粒、湿粒干燥、整粒、包装工序。本安神养心冲剂按照中医组方原则制造,能够产生协同作用,虚实同治、标本兼顾,具有安神养心、清热解毒、美容护肤、健脾胃、补益气等保健养生功效。
Description
技术领域
本发明涉及一种冲剂,尤其是涉及一种安神养心冲剂及其制备方法。
背景技术
随着生活节奏的加快,人们学习、工作和生活的压力越来越大。长期在办公室工作,身体缺乏锻炼。我们生活中的环境污染和噪音也在影响着我们的身心健康。头晕耳鸣、头痛眩晕、神疲乏力、失眠健忘、食少倦怠、抑郁、焦虑、心悸、气短、盗汗等发病率呈上升趋势,严重影响着人们的身心健康。
中国专利CN 101708281 B公布了一种养心安神的中药制剂及其制备方法,制成其药效成分的原料药由下述重量配比的组分构成:牛蒡子根25-35、黄芪15-25、酸枣仁15-25、黄精10-20熟地黄5-15、人参5-15、麦冬5-15、当归5-15、白芍5-15、丹皮5-15、白术5-15、甘草1-5。
发明内容
本发明的目的在于提出一种疗效稳定、无副作用的安神养心冲剂及其制备方法。
本发明所采用的技术方案是:
一种安神养心冲剂,其由以下重量份数比的原料制备而成,其中,主料:灵芝3-6份、女贞子1-3份、龙眼干2-5份、甘草1-2份、酸枣仁2-6份、绞股蓝2-4份、合欢皮1-3份、丹参2-3份、柏子仁1-3份、桑葚子1-4份,辅料:淀粉35-80份、精糊15-55份。
以上所述安神养心冲剂,其由以下重量份数比的原料制备而成,其中,主料:灵芝5份、女贞子2份、龙眼干3份、甘草2份、酸枣仁3份、绞股蓝2份、合欢皮2份、丹参3份、柏子仁1份、桑葚子2份,辅料:淀粉50份、精糊30份。
制备上述安神养心冲剂的制备方法,包括粉碎、提取、浓缩干燥、制粒、湿粒干燥、整粒、包装工序,制备得到安神养心冲剂,具体操作步骤如下:
(1)粉碎:按重量份数称取主料,将主料用粉碎机粉碎,过20-40目筛;
(2)提取:将上述主料放入煎煮容器中,加入4-8倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入4-8倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入2-5倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.30-1.35;
(3)浓缩干燥:在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到20%—50%后,在35-50℃进行喷雾干燥,制成浸膏粉;
(4)制粒:将上述重量份数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;
(5)湿粒干燥:干燥时温度逐渐升高,控制在60-80℃,制成含水量控制在3%—5%的颗粒;
(6)整粒:将上述颗粒过12-14目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;
(7)包装:将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
本安神养心冲剂采用的主料的药理药性如下:
1、灵芝(Ganoderma Lucidum Karst),别称:赤芝、红芝、木灵芝、菌灵芝、万年蕈、灵芝草等。主含氨基酸、多肽、蛋白质、真菌溶菌酶以及糖类、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、维生素B2及C等。味甘性平,入心经,能补心血、益心气、安心神,故可用治气血不足、心神失养所致的心神不宁、失眠、惊悸、多梦、健忘、体倦神疲、食少等症。
2、女贞子(Fructus Ligustri Lucidi),别称:女贞实、冬青子、爆格蚤、白蜡树子、鼠梓子等。女贞子果实含齐墩果酸、甘露醇、葡萄糖、棕榈酸、硬脂酸、油酸及亚麻酸、果皮含熊果酸、齐墩果酸、乙酰齐墩果酸及铜、锌、铁、锰等微量元素。性味:甘,苦,平。归经:肝;肾经。主治:头昏目眩,腰膝酸软,遗精,耳鸣,须发早白,骨蒸潮热,目暗不明。
3、龙眼干(Dried longan),别称:桂圆干、益智等。含有硫胺素、核黄素、尼克酸、抗坏血酸等化学成份,性平,味甘,入心、肝、脾、肾经。具有益气补血,安神定志,养血安胎的功效。适用于失眠健忘,脾虚腹泻,精神不振等症。
4、甘草(Glycyrrhiza uralensis Fisch),别名:国老、甜草、乌拉尔甘草、甜根子等。从甘草中分离的化合物包括甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物,甘草甜素和黄酮类物质是甘草中最重要的生理活性物质。味甘,气平,性缓。入足太阴脾、足阳明胃经。用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力、气喘咳嗽、咽喉肿痛、缓解咳嗽,祛痰,消炎平喘等。
5、酸枣核(Ziziphus jujuba Mill.var.spinosa),别称:枣仁、酸枣核、山枣仁、酸枣、酸枣核、酸枣子、棘仁等。含多量脂肪油和蛋白质,并含甾醇、三萜类、酸枣仁皂甙、多量维生素C。性味:甘,平。归经:心经;脾经;肝经;胆经。主治:虚烦不眠;惊悸怔忡;体虚自汗、盗汗。
6、绞股蓝(Fiveleaf Gynostemma Herb),别名:七叶胆、五叶参、七叶参、小苦药等。含有蛋白质、脂肪、膳食纤维、碳水化合物、钙、磷、铁、胡萝卜素、维生素B1、维生素B2、尼克酸、维生素C以及多种微量元素等成分。绞股蓝性寒,味苦;归肺、脾、肾经。具有消除疲劳、延缓衰老、镇静催眠、降低血脂、降低胆固醇、降低转氨酶、增强食欲、解毒、止咳祛痰等功效。主治高血压病、高脂血症、心脑血管病、胃溃疡,并有利于乌发美容、健脑壮阳、抗衰老等。
7、合欢皮(Silktree Albizia Bark),别称:合昏皮、夜台皮、合欢木皮。性味甘、平。归经:入心、肝经。合欢干皮中含木脂体糖甙,合欢三萜内酯甲、鞣质等,有解郁、和血、宁心、消痈肿之功。有治心神不安、忧郁、失眠、肺痈、痈肿、瘰疠、筋骨折伤之效。
8、丹参(Salvia miltiorrhiza Bunge),别称:紫丹参、红根、血参根、大红袍。主含脂溶性的二萜类成分和水溶性的酚酸成分,还含黄酮类,三萜类,甾醇等其他成分。性味苦,微寒。归心、肝经。有祛瘀止痛,活血通经,清心除烦之功效。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。
9、柏子仁【Platycladus orientalis (Linn.)】,别称:柏仁、柏子、柏实、侧柏仁。含有脂肪油约14 %,多为不饱和脂肪酸组成,还含有少量挥发油,皂甙、蛋白质、钙、磷、铁多种维生素等。柏子仁性平味甘。具养心安神、润肠通便的功效。治惊悸、失眠、遗精、盗汗、便秘等症。
10、桑椹子(Morus alba L),别名:桑实、葚、乌椹、文武实、黑椹、桑枣、桑椹子、桑粒、桑果。桑葚果实中含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质等成分,营养是苹果的5-6倍,是葡萄的4倍。中医药学认为,桑椹子味甘,性凉,归心、肝、肾经,主肝肾不足和血虚精亏的头晕目眩;腰酸耳鸣;须发早白;失眠多梦;津伤口渴;消渴;肠燥便秘等功效。
本发明的有益效果:
1、本安神养心冲剂是根据中医对养生的理论和施治原理,按照中医组方原则制造,能够产生协同作用,虚实同治、标本兼顾,既补充人体细胞活力,又能促进人体的生态平衡,提高抵抗力,安神养心的保健作用。
2、本安神养心冲剂制备方法简单,整个制备过程保留并利用了蛋白质、糖类化合物、酚类化合物、黄酮类化合物、生物碱类等活性成份,产品质量高。
3、本安神养心冲剂具有安神养心、清热解毒、美容护肤、健脾胃、补益气等保健养生功效。
4、本安神养心冲剂配方合理,对人安全可靠,无毒副作用,使用人群广。
具体实施方式
下面结合具体实施例对本发明作进一步说明。
一、制备实施例
实施例1:
1、原料和重量数
主料:灵芝30克、女贞子20克、龙眼干50克、甘草10克、酸枣仁60克、绞股蓝20克、合欢皮20克、丹参20克、柏子仁10克、桑葚子30克,辅料:淀粉550克、精糊400克。
2、制备方法
按重量数称取主料,将主料用粉碎机粉碎,过30目筛;将过筛后的主料放入煎煮容器中,加入8倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入8倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入5倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.30;在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到20%后,在35℃进行喷雾干燥,制成浸膏粉;将上述重量数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;将湿粒进行干燥,干燥时温度逐渐升高,控制在60℃,制成含水量控制在3%的颗粒;将上述颗粒过12目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
实施例2:
1、原料和重量数
主料:灵芝60克、女贞子10克、龙眼干30克、甘草20克、酸枣仁20克、绞股蓝40克、合欢皮10克、丹参20克、柏子仁30克、桑葚子40克,辅料:淀粉800克、精糊150克。
2、制备方法
按重量数称取主料,将主料用粉碎机粉碎,过20目筛;将过筛后的主料放入煎煮容器中,加入7倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入7倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入3倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.30;在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到30%后,在40℃进行喷雾干燥,制成浸膏粉;将上述重量数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;将湿粒进行干燥,干燥时温度逐渐升高,控制在70℃,制成含水量控制在4%的颗粒;将上述颗粒过12目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
实施例3:
1、原料和重量数
主料:灵芝50克、女贞子20克、龙眼干30克、甘草20克、酸枣仁30克、绞股蓝20克、合欢皮20克、丹参30克、柏子仁10克、桑葚子20克,辅料:淀粉500克、精糊300克。
2、制备方法
按重量数称取主料,将主料用粉碎机粉碎,过35目筛;将过筛后的主料放入煎煮容器中,加入6倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入6倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入3倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.35;在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到35%后,在50℃进行喷雾干燥,制成浸膏粉;将上述重量数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;将湿粒进行干燥,干燥时温度逐渐升高,控制在75℃,制成含水量控制在5%的颗粒;将上述颗粒过14目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
实施例4:
1、原料和重量数
主料:灵芝40克、女贞子30克、龙眼干20克、甘草10克、酸枣仁40克、绞股蓝30克、合欢皮30克、丹参30克、柏子仁20克、桑葚子10克,辅料:淀粉350克、精糊550克。
2、制备方法
按重量数称取主料,将主料用粉碎机粉碎,过40目筛;将过筛后的主料放入煎煮容器中,加入4倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入4倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入2倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.35;在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到50%后,在45℃进行喷雾干燥,制成浸膏粉;将上述重量数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;将湿粒进行干燥,干燥时温度逐渐升高,控制在80℃,制成含水量控制在5%的颗粒;将上述颗粒过12目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
二、试用实施例
试用例1
李X:男性,35岁,职业:教师,因教学工作重,体内肝气旺盛,口干舌燥、失眠多梦、须发早白、便秘。根据本人情况和接受程度,每天早晚各服用一包,饮用时只需将颗粒倒入杯中,温水冲,到融化即可服用。服用15天后,大便顺畅;服用30天后,能按时入睡,睡眠深。
试用例2
张X:男性,68岁,职业:退休老同志,失眠健忘、精神不振、体虚盗汗、心神不安、少食。根据本人情况和接受程度,每天早晚各服用一包,饮用时只需将颗粒倒入杯中,温水冲,到融化即可服用。服用15天后,食量增大;服用30天后,精力充沛,记忆力增强。
试用例3
王X:女性,26岁,职业:文员,工作繁忙,经常加班,导致面部发黄、心烦气躁、气血虚弱、月经不调、头晕目眩。根据本人情况和接受程度,每天早晚各服用一包,饮用时只需将颗粒倒入杯中,温水冲,到融化即可服用。服用15天后,睡眠质量好转;服用30天后,气色红润,情绪平稳。
Claims (3)
1.一种安神养心冲剂,其特征在于:其由以下重量份数比的原料制备而成,其中,主料:灵芝3-6份、女贞子1-3份、龙眼干2-5份、甘草1-2份、酸枣仁2-6份、绞股蓝2-4份、合欢皮1-3份、丹参2-3份、柏子仁1-3份、桑葚子1-4份,辅料:淀粉35-80份、精糊15-55份。
2.根据权利要求1所述的安神养心冲剂,其特征在于:其由以下重量份数比的原料制备而成,其中,主料:灵芝5份、女贞子2份、龙眼干3份、甘草2份、酸枣仁3份、绞股蓝2份、合欢皮2份、丹参3份、柏子仁1份、桑葚子2份,辅料:淀粉50份、精糊30份。
3.一种制备如权利要求1所述的安神养心冲剂的方法,其特征在于:包括粉碎、提取、浓缩干燥、制粒、湿粒干燥、整粒、包装工序,制备得到安神养心冲剂,具体操作步骤如下:
粉碎:按重量份数称取主料,将主料用粉碎机粉碎,过20-40目筛;
提取:将上述筛后的主料放入煎煮容器中,加入4-8倍重量份的水,煎煮,煮沸2个小时,纱布过滤取煎出液,药渣再次加入4-8倍水煎煮,煮沸1小时,纱布过滤,合并两次煎出液,将煎出液蒸发至1:1的比重,冷却后加入2-5倍的乙醇,充分混匀,放置24小时,沉淀,取上清液,蒸发浓缩至稠膏,稠膏的比重为1.30-1.35;
浓缩干燥:在真空度1.33kPa,温度40℃下将稠膏进行浓缩,浓缩到20%—50%后,在35-50℃进行喷雾干燥,制成浸膏粉;
制粒:将上述重量份数的辅料与浸膏粉混合均匀,加入少量90%的乙醇为润湿剂制成软材,用挤压造粒机制成湿粒;
湿粒干燥:干燥时温度逐渐升高,控制在60-80℃,制成含水量控制在3%—5%的颗粒;
整粒:将上述颗粒过12-14目的筛,将大颗粒磨碎,再过60目的筛除去细小颗粒和细粉即可得到安神养心颗粒;
包装:将上述安神养心颗粒消毒灭菌后用复合铝塑袋密封包装成10g的小包即得安神养心冲剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410815503.4A CN104606338A (zh) | 2014-12-25 | 2014-12-25 | 一种安神养心冲剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410815503.4A CN104606338A (zh) | 2014-12-25 | 2014-12-25 | 一种安神养心冲剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104606338A true CN104606338A (zh) | 2015-05-13 |
Family
ID=53141158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410815503.4A Pending CN104606338A (zh) | 2014-12-25 | 2014-12-25 | 一种安神养心冲剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104606338A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250369A (zh) * | 2015-11-19 | 2016-01-20 | 哈尔滨圣吉药业股份有限公司 | 一种用于产后腰腹疼痛、头痛身酸的颗粒及其制备方法 |
| CN110151875A (zh) * | 2019-05-21 | 2019-08-23 | 陕西金象制药有限公司 | 一种龙枣胶囊及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101053433A (zh) * | 2007-04-30 | 2007-10-17 | 陈江 | 养心安神饮料 |
| CN102106998A (zh) * | 2011-01-19 | 2011-06-29 | 朱长义 | 舒心宁眠中药 |
-
2014
- 2014-12-25 CN CN201410815503.4A patent/CN104606338A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101053433A (zh) * | 2007-04-30 | 2007-10-17 | 陈江 | 养心安神饮料 |
| CN102106998A (zh) * | 2011-01-19 | 2011-06-29 | 朱长义 | 舒心宁眠中药 |
Non-Patent Citations (3)
| Title |
|---|
| 曹振爱: "芪杞汤治疗神经衰弱60例", 《陕西中医》 * |
| 贾玉梅等: "安神药配伍规律及临床应用浅析", 《中医学报》 * |
| 陈倩等: "女贞子:安神健体", 《千古中医千古事:细说中医源流典故》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250369A (zh) * | 2015-11-19 | 2016-01-20 | 哈尔滨圣吉药业股份有限公司 | 一种用于产后腰腹疼痛、头痛身酸的颗粒及其制备方法 |
| CN110151875A (zh) * | 2019-05-21 | 2019-08-23 | 陕西金象制药有限公司 | 一种龙枣胶囊及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101642540B (zh) | 一种镇静安神的中成药 | |
| CN101485830B (zh) | 一种中药抗衰老保健胶囊 | |
| CN101982082B (zh) | 一种养心草复合保健茶 | |
| CN101856430A (zh) | 预防亚健康的绿色膏滋补品灵芝(三仙)膏及其制备方法 | |
| CN102335335A (zh) | 一种保健、缓解体力疲劳的中药制剂 | |
| CN101804165A (zh) | 一种清肾毒,强健五脏六腑,增强体质延缓衰老的制剂及其制备方法 | |
| CN102824533A (zh) | 一种抗氧化中药组合物及其制备方法 | |
| CN101502588B (zh) | 一种美容祛痘组合物及其制备方法 | |
| CN101537120A (zh) | 一种养颜益寿保健品 | |
| CN105918946B (zh) | 一种枣杞养肝组合物、颗粒剂及其制备方法 | |
| CN107744569A (zh) | 一种具有养发、生发功效的精华液及其制备方法 | |
| CN111406816A (zh) | 茶汤五种颜色的系列代用茶及其制备方法 | |
| CN101468103A (zh) | 一种护肝产品及其制备方法 | |
| CN106511781A (zh) | 一种水丸剂 | |
| CN102380013A (zh) | 一种先兆性流产、习惯性流产的药物组合物及其制备方法 | |
| CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
| CN104606338A (zh) | 一种安神养心冲剂及其制备方法 | |
| CN101744969B (zh) | 治疗失眠的药物组合物及其制备方法 | |
| CN108887544A (zh) | 一种天然养生饮料 | |
| CN104606577A (zh) | 一种排毒养颜冲剂及其制备方法 | |
| CN101474356A (zh) | 一种治疗脊髓及相关疾病的中药颗粒剂 | |
| CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
| CN104474459A (zh) | 具有保肝作用的中药制剂及其制备方法 | |
| CN103735713B (zh) | 一种改善营养性贫血的中药组合物及其制备方法 | |
| CN106138684A (zh) | 一种用于补肾丰胸的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150513 |